Ruth Devenyns joins Korys Direct Investments
Ruth joined Korys in June 2012 as an Investment Director in the Direct Investments team, with a primary focus on life sciences. Ruth has a long standing experience in the biotechnology sector. A former analyst and investment banker, she was in charge of the venture capital activities in the sector at KBC Private Equity until end of March 2012. She was involved in several IPO’s, private placements and M&A-transactions and held various directorships including Ablynx, Applied Maths and Pronota. At KBC Private Equity she also managed various investments in agro-biotech and seed companies such as CropDesign and Ceres. Currently, Ruth is an independent director in 2 Euronext-listed companies (MDx Health and Devgen) and director of FlandersBio, the biotech sector organisation in Flanders.